Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.
-
Upload
liliana-morrison -
Category
Documents
-
view
213 -
download
0
Transcript of Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.
![Page 1: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/1.jpg)
Collaboration with the COPDgene Group & priorities for REGRichard Martin9:40–10.00
![Page 2: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/2.jpg)
Initiatives
• Validation of end points• Validation of real-life diagnostic criteria
where no code exists• Health care utilization and therapy in
COPD based on CT lung phenotyping
![Page 3: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/3.jpg)
COPDgene Group
• ~10,000 COPD patients well-categorized• Unique
o CT lung phenotyping– Emphysema ±– Air trapping ±– Mixture
o Social security numberso ⅓ are black
• Medicare database (≥ 65 y/o)
![Page 4: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/4.jpg)
COPDgene Group
• Telephone survey—symptoms • Not health care utilization• Not by CT phenotype
![Page 5: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/5.jpg)
COPDgene Patients: real-life trials• Health care utilization by CT phenotype
o Hospitalizations– O2 use– Meds– Procedures– Other costs – ICU, etc.
• EDo As above
• Above for blacks (1/3 of sample size)• Influenza/Pneumovac vaccinations (?)
![Page 6: Collaboration with the COPDgene Group & priorities for REG Richard Martin 9:40–10.00.](https://reader035.fdocuments.in/reader035/viewer/2022062721/56649f1e5503460f94c35198/html5/thumbnails/6.jpg)
Funding
• NHLBI ancillary trials—D/C
• PharmaoBIoGSKoAZ